Pearce IP BioBlast w/e 8 March 2024
On 9 March 2024, Samsung Bioepis presented two papers of study results for its immunology portfolio at the 2024 American Academy of Dermatology (AAD)…
Source: lexology.com
Approval Alert News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Approval Alert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Approval Alert Today - Breaking & Trending Today
Pearce IP BioBlast w/e 26 Jan 2024
AbbVie announced it will invest US$233M in its biologics manufacturing facility in Singapore. The investment will add 24,000L of biologics…
Source: lexology.com
BioBlast w/e 15 Dec 23
Korea Biomed reported that LG Chem’s Xelenka®, biosimilar to AbbVie’s Humira® (adalimumab), has been approved by the Korean Ministry of Food and Drug…
Source: lexology.com
BioBlast w/e 08 Dec 23
The FDA approved Vertex/CRISPR Therapeutics’ Casgevy® and Bluebird Bio’s Lyfgenia®, the first cell-based gene therapies to treat sickle cell disease…
Source: lexology.com
BioBlast w/e 17 Nov 23
AstraZeneca (AZ) announced the FDA approved its Truqap® (capivasertib) in combination with Faslodex (fulvestrant) for the treatment of adult patients…
Source: lexology.com